Psoriasis Drugs Market

Psoriasis Drugs Market Size by Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors and Others), Treatment (Topicals, Systemic, Biologics), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12599
  • Published Date: Oct, 2021
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

Market Dynamics

Drivers

  • The awareness regarding the treatment and improved healthcare infrastructure

The rise in per capita income of the people in the developed and developing countries and the increase in the infrastructure of the healthcare system in the developed and developing region are playing an important part in the growth of the psoriasis market. People with increased disposable income want to live a quality life and want good treatment for the diseases they are suffering. This has made them aware about the types of treatment available. People who are suffering from Psoriasis are now aware of the medicines and therapies available to cure it. Also, the improvement in the healthcare infrastructure allows people to take quality treatment in the area closer to them then to go to some other cities for it. These factors are driving the Psoriasis drugs market.

  • The increasing cases of unhealthy eating habits

According to the experts, psoriasis happens due to the genetic and environmental condition. The surge in disposable income of the people in the developed and developing countries have changed their lifestyle. The unhealthy lifestyle with unhealthy eating habits with the consumption of alcohol in their daily life activity are some of the reasons which are causing psoriasis. The smoking and sedentary living are also some of the activity that is making people more prone to such conditions. The increased per capita income have given them access to quality treatment. This has made them aware of the illness and the cause of it. So the rising unhealthy lifestyle of the people is also driving the market.

Restraints

  • The high cost of psoriasis therapies

There are many treatment for the psoriasis illness. Some are creams, moisturizers, ointment and retinoid creams which reduces the growth rate of new skin cell and others gives relives from itching and dry skin. Some of the medication have severe side effects like retinoid creams, pills, lotions and gels can cause side effects like birth defects. So they should not be recommended to women who are pregnant. Similarly, methotrexate can lead to bone marrow and liver-related diseases. The drugs which are taken to cure it may damage the kidney and raise blood pressure. The developing biological treatment are also blocking the immune system. The most popular therapy, in this case, is an enzyme inhibitor, but this medication has a high cost. All such factors are acting as a restraint for the market.

Opportunities

  • The increasing demand for tailored made solutions for the diseases.

In recent years with the advancement in technologies and the growing knowledge about the disease the medicine or the solution is now shifting from one-drugs-fits all solution to tailored made plan, this mostly possible because of the rise in availability of predictive biomarkers. Thou the developing biological treatment may block the immune system, but this is becoming very effective in curing psoriasis. This scenario is creating an opportunity for the psoriasis treatment market. The treatment is also shifting towards the molecular medicine; this is happening due to the growing knowledge and much more understandings of the disease and which detect fundamental molecular and the genetic error of the disease.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Therapeutic Class
          4.3.2. Market Attractiveness Analysis By Treatment
          4.3.3. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
    5.3. Restraints
    5.4. Opportunities
    5.5. Challenges

6. Global Psoriasis Drugs Market Analysis and Forecast, By Therapeutic Class
    6.1. Segment Overview
    6.2. Tumor Necrosis Factor Inhibitor
    6.3. Interleukin Inhibitors
    6.4. Others

7. Global Psoriasis Drugs Market Analysis and Forecast, By Treatment
    7.1. Segment Overview
    7.2. Topicals
    7.3. Systemic
    7.4. Biologics

8. Global Psoriasis Drugs Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Psoriasis Drugs Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Psoriasis Drugs Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. AbbVie Inc
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Amgen Inc
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. Johnson & Johnson
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Novartis AG
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. Eli Lilly & Company
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. AstraZeneca
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Celgene Corporation
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. UCB
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Merck
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Boehringer Ingelheim
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. LEO Pharma
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
 

List of Table

1. Global Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

2. Global Tumor Necrosis Factor Inhibitor Psoriasis Drugs  Market, By Region, 2018–2028 (USD Billion)

3. Global Interleukin Inhibitors Psoriasis Drugs  Market, By Region, 2018–2028 (USD Billion)

4. Global Others Psoriasis Drugs  Market, By Region, 2018–2028 (USD Billion)

5. Global Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

6. Global Topicals, Psoriasis Drugs Market, By Region, 2018–2028 (USD Billion)

7. Global Systemic, Psoriasis Drugs Market, By Region, 2018–2028 (USD Billion)

8. Global Biologics, Psoriasis Drugs Market, By Region, 2018–2028 (USD Billion)

9. Global Psoriasis Drugs Market, By Region, 2018–2028 (USD Billion)

10. Global Psoriasis Drugs Market, By North America, 2018–2028 (USD Billion)

11. North America Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

12. North America Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

13. U.S. Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

14. U.S. Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

15. Canada Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

16. Canada Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

17. Mexico Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

18. Mexico Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

19. Europe Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

20. Europe Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

21. Germany Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

22. Germany Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

23. France Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

24. France Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

25. U.K. Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

26. U.K. Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

27. Italy Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

28. Italy Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

29. Spain Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

30. Spain Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

31. Asia Pacific Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

32. Asia Pacific Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

33. Japan Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

34. Japan Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

35. China Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

36. China Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

37. India Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

38. India Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

39. South America Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

40. South America Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

41. Brazil Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

42. Brazil Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

43. Middle East and Africa Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

44. Middle East and Africa Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

45. UAE Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

46. UAE Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

47. South Africa Psoriasis Drugs Market, By Therapeutic Class, 2018–2028 (USD Billion)

48. South Africa Psoriasis Drugs Market, By Treatment, 2018–2028 (USD Billion)

List of Figures 

1. Global Psoriasis Drugs Market Segmentation

2. Psoriasis Drugs Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Psoriasis Drugs Market Attractiveness Analysis By Therapeutic Class  

9. Global Psoriasis Drugs Market Attractiveness Analysis By Treatment  

10. Global Psoriasis Drugs Market Attractiveness Analysis By Region

11. Global Psoriasis Drugs Market: Dynamics

12. Global Psoriasis Drugs Market Share By Therapeutic Class (2021 &2028)

13. Global Psoriasis Drugs Market Share by Treatment (2021 &2028)

14. Global Psoriasis Drugs Market Share by Regions (2021 &2028)

15. Global Psoriasis Drugs Market Share by Company (2020)

This study forecasts revenue at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global Psoriasis Drugs market on the basis of below mentioned segments:

Global Psoriasis Drugs Market by Therapeutic Class:

  • Tumor Necrosis Factor Inhibitor
  • Interleukin Inhibitors
  • Others

Global Psoriasis Drugs Market by Treatment:

  • Topicals
  • Systemic
  • Biologics

Global Psoriasis Drugs Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date